Need for Rapid COVID-19 Testing to Accelerate Growth of Polymerase Chain Reaction (PCR) Market

Industry Insights

COVID-19 has been the worst pandemic ever in the history of mankind. Every nation in the world is trying hard to free itself from the horrendous clutches of the SARS-CoV-2 outbreak. For this, maximum testing of individuals is necessary. Therefore, the polymerase chain reaction (PCR) market is expected to gather considerable steam in terms of growth. Polymerase chain reaction (PCR) is a technique that is used to make numerous copies of a specific DNA sample, sometimes in millions or billions.

Reverse transcription polymerase chain reaction (RT-PCR) machine technologies to help in speedy COVID-19 testing

One of the most effective COVID-19 testing methods is the reverse transcription polymerase chain reaction (RT-PCR) testing. Some viruses like the novel coronavirus contain only RNA. For detecting coronavirus using RT-PCR, scientists need to convert RNA to DNA. This process is called reverse transcription. The testing starts with the insertion of a swab that goes up the nose into the throat. This swab collects saliva, cell bits, mucous, and viral RNA if present. After reverse transcription, the DNA is inserted in an RT-PCR testing machine.

RT-PCR testing machines are expected to act as growth accelerators for the polymerase chain reaction (PCR) market. Many technologies are expected to add up for quick COVID-19 testing. For instance, DnaNudge’s NudgeBox analyzer is a new COVID-19 screening device that enables speedy lab-free PCR testing. It has been recently clinically validated and the results are delivered in an hour. Hence, such technologies may propel the growth rate of the polymerase chain reaction (PCR) market.

To Get an Exhaustive Overview about the Competition in Polymerase Chain Reaction (PCR) Market, Request for a Report Brochure at

In addition, quick FDA approvals are also expected to boost the growth rate of the polymerase chain reaction (PCR) market. For instance, Mes Biotech received emergency-use authorization for a new PCR-based Accula ™ SARS-CoV-2 test that can deliver test results within 30 minutes. Therefore, the polymerase chain reaction (PCR) market is expected to climb the growth ladder at a faster rate.

Leave a Reply